NCT03893461 (CISTRON) is a clinical trial of x in Thromboembolism, sponsored by Odense University Hospital.

Who is sponsoring NCT03893461?

NCT03893461 is sponsored by Odense University Hospital.

What drugs are being tested in NCT03893461?

Interventions in NCT03893461: x.

What condition does NCT03893461 study?

NCT03893461 studies Thromboembolism, Lung Cancer, NSCLC, Radiotherapy; Complications.

Is NCT03893461 still recruiting?

NCT03893461 is currently status unknown. Last updated 22 July 2021.

Last reviewed 2021-07-22 · How we verify

NCT03893461: CISTRON

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Coagulation System In STereotactic Radiotherapy Of NSCLC

Status unknown Last updated 22 July 2021

What this trial tests

trial testing x in Thromboembolism in 110 participants. Status unknown.

Timeline

26 March 2019

Primary endpoint
30 June 2021

31 December 2022

Quick facts

Lead sponsor	Odense University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	110
Start date	26 March 2019
Primary completion	30 June 2021
Estimated completion	31 December 2022
Sites	1 location across Denmark

Drugs / interventions tested

Conditions studied

Thromboembolism — all drugs for Thromboembolism →
Lung Cancer — all drugs for Lung Cancer →
NSCLC — all drugs for NSCLC →
Radiotherapy; Complications — all drugs for Radiotherapy; Complications →

Sponsor

Odense University Hospital

Who can join

18 and older, any sex, with Thromboembolism or Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The risk of thromboembolism is elevated in lung cancer patients. The present project investigates whether stereotactic body radiation therapy (SBRT) further increases the risk of thromboembolic disease in lung cancer patients. If coagulation is activated by SBRT, this study could form the basis of new clinical trials investigating whether lung cancer patients may benefit from thromboprophylaxis during and after stereotactic body radiation therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of Stereotactic Body Radiotherapy on Thrombin Generation and Platelet Aggregation in Patients with Non-Small Cell Lung Cancer.
Bentsen KK, Hojbjerg JA, Vinholt PJ, Hansen O, et al · · 2023 · cited 2× · PMID 38009051 · DOI 10.1177/10760296231216962

Verify or expand the search:

Other recruiting trials for Thromboembolism

Currently open trials in the same condition.

NCT06657924 — Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery · Phase 2 · recruiting
NCT06442267 — Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support · Phase 4 · recruiting
NCT06443905 — Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patients · active not recruiting
NCT05301348 — In Vivo Detection of Circulating Clots in Patients With Thromboembolism · NA · recruiting
NCT06627933 — Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement · recruiting

Other Odense University Hospital trials

Trials by the same sponsor.

NCT07163091 — Bracing After Ankle Fracture · NA · not yet recruiting
NCT07521696 — Physical Recovery During Bracing After Ankle Fracture (Re-BAF) · NA · not yet recruiting
NCT07466212 — QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy · not yet recruiting
NCT07191379 — Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma · Phase 4 · not yet recruiting
NCT07170085 — Positioning of Children With Acute Respiratory Insufficiency · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03893461 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Odense University Hospital
Last refreshed: 22 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03893461.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing